An embarrassment of riches: An update on the symptomatic treatment of canine atopic dermatitis.
作者信息
Gortel Kinga
机构信息
Westbank Animal Care Hospital, West Kelowna, British Columbia.
出版信息
Can Vet J. 2018 Sep;59(9):1013-1016.
Abstract
摘要
相似文献
1
An embarrassment of riches: An update on the symptomatic treatment of canine atopic dermatitis.财富的尴尬：犬特应性皮炎对症治疗的最新进展
Can Vet J. 2018 Sep;59(9):1013-1016.
2
Treatment of canine atopic dermatitis with cyclosporine: a pilot clinical study.环孢素治疗犬特应性皮炎的初步临床研究。
Vet Rec. 2001 May 26;148(21):662-3. doi: 10.1136/vr.148.21.662.
3
The role of oclacitinib in the management of ischaemic dermatopathy in four dogs.奥克拉替尼在四只犬缺血性皮肤病治疗中的作用。
Vet Dermatol. 2019 Jun;30(3):201-e63. doi: 10.1111/vde.12743. Epub 2019 Apr 21.
4
A blinded, randomized clinical trial comparing the efficacy and safety of oclacitinib and ciclosporin for the control of atopic dermatitis in client-owned dogs.一项比较奥克拉替尼和环孢素在控制宠物狗特应性皮炎方面的疗效和安全性的双盲、随机临床试验。
Vet Dermatol. 2015 Feb;26(1):23-30, e7-8. doi: 10.1111/vde.12186. Epub 2014 Dec 12.
5
An update on the treatment of canine atopic dermatitis.犬特应性皮炎治疗的最新进展。
Vet J. 2016 Jan;207:29-37. doi: 10.1016/j.tvjl.2015.09.016. Epub 2015 Sep 16.
6
Ciclosporin in canine dermatology: a decade of comfort.环孢素在犬类皮肤病学中的应用：十年的成效。
Vet Rec. 2014 Mar;174 Suppl 2(Suppl 2):1-2. doi: 10.1136/vr.g2152.
7
Long-term compassionate use of oclacitinib in dogs with atopic and allergic skin disease: safety, efficacy and quality of life.奥克拉替尼在患有特应性和过敏性皮肤病的犬类中的长期同情用药：安全性、有效性和生活质量
Vet Dermatol. 2015 Jun;26(3):171-9, e35. doi: 10.1111/vde.12194. Epub 2015 Feb 16.
8
Treatment of canine atopic dermatitis: 2010 clinical practice guidelines from the International Task Force on Canine Atopic Dermatitis.犬异位性皮炎的治疗：国际犬异位性皮炎特别工作组2010年临床实践指南
Vet Dermatol. 2010 Jun;21(3):233-48. doi: 10.1111/j.1365-3164.2010.00889.x. Epub 2010 Apr 23.
9
Cyclosporine in veterinary dermatology.环孢素在兽医皮肤病学中的应用
Vet Clin North Am Small Anim Pract. 2013 Jan;43(1):153-71. doi: 10.1016/j.cvsm.2012.09.007.
10
Efficacy of oclacitinib (Apoquel®) compared with prednisolone for the control of pruritus and clinical signs associated with allergic dermatitis in client-owned dogs in Australia.在澳大利亚，比较奥克拉替尼（爱波克®）与泼尼松龙对控制宠物犬过敏性皮炎相关瘙痒及临床症状的疗效。
Vet Dermatol. 2014 Dec;25(6):512-8, e86. doi: 10.1111/vde.12166. Epub 2014 Aug 11.
引用本文的文献
1
West Highland White Terriers under primary veterinary care in the UK in 2016: demography, mortality and disorders.2016年英国接受初级兽医护理的西部高地白梗犬：人口统计学、死亡率及病症
Canine Genet Epidemiol. 2019 Sep 3;6:7. doi: 10.1186/s40575-019-0075-2. eCollection 2019.
本文引用的文献
1
Vaccination against IL-31 for the treatment of atopic dermatitis in dogs.针对犬特应性皮炎治疗的抗白细胞介素-31疫苗接种。
J Allergy Clin Immunol. 2018 Jul;142(1):279-281.e1. doi: 10.1016/j.jaci.2017.12.994. Epub 2018 Apr 4.
2
Vitamin D shows in vivo efficacy in a placebo-controlled, double-blinded, randomised clinical trial on canine atopic dermatitis.在一项针对犬特应性皮炎的安慰剂对照、双盲、随机临床试验中，维生素D显示出体内疗效。
Vet Rec. 2018 Apr 7;182(14):406. doi: 10.1136/vr.104492. Epub 2018 Feb 1.
3
A blinded, randomized clinical trial evaluating the efficacy and safety of lokivetmab compared to ciclosporin in client-owned dogs with atopic dermatitis.一项双盲随机临床试验，评估洛维单抗与环孢素相比，对患有特应性皮炎的宠物犬的疗效和安全性。
Vet Dermatol. 2017 Dec;28(6):593-e145. doi: 10.1111/vde.12478. Epub 2017 Sep 14.
4
Emerging role of interleukin-31 and interleukin-31 receptor in pruritus in atopic dermatitis.白细胞介素-31 和白细胞介素-31 受体在特应性皮炎瘙痒中的新作用。
Allergy. 2018 Jan;73(1):29-36. doi: 10.1111/all.13239. Epub 2017 Jul 20.
5
A blinded, randomized, placebo-controlled, dose determination trial of lokivetmab (ZTS-00103289), a caninized, anti-canine IL-31 monoclonal antibody in client owned dogs with atopic dermatitis.一项关于洛维妥单抗（ZTS-00103289）的双盲、随机、安慰剂对照、剂量确定试验，洛维妥单抗是一种犬源化的抗犬白细胞介素-31单克隆抗体，用于患有特应性皮炎的宠物犬。
Vet Dermatol. 2016 Dec;27(6):478-e129. doi: 10.1111/vde.12376. Epub 2016 Sep 19.
6
A blinded, randomized, placebo-controlled trial of the safety of lokivetmab (ZTS-00103289), a caninized anti-canine IL-31 monoclonal antibody in client-owned dogs with atopic dermatitis.一项关于洛维单抗（ZTS-00103289）安全性的双盲、随机、安慰剂对照试验，洛维单抗是一种犬源化抗犬白细胞介素-31单克隆抗体，用于患有特应性皮炎的宠物犬。
Vet Dermatol. 2016 Dec;27(6):505-e136. doi: 10.1111/vde.12364. Epub 2016 Sep 19.
7
Efficacy of proactive long-term maintenance therapy of canine atopic dermatitis with 0.0584% hydrocortisone aceponate spray: a double-blind placebo controlled pilot study.0.0584% 醋酸氢化可的松喷雾剂对犬异位性皮炎的长期主动维持治疗效果：一项双盲安慰剂对照的初步研究。
Vet Dermatol. 2016 Apr;27(2):88-92e25. doi: 10.1111/vde.12285. Epub 2016 Jan 25.
8
Repeated oral dose tolerance in dogs treated concomitantly with ciclosporin and oclacitinib for three weeks.环孢素与奥克拉替尼同时给药三周的犬重复口服剂量耐受性研究
Vet Dermatol. 2016 Feb;27(1):22-e7. doi: 10.1111/vde.12278. Epub 2015 Dec 11.
9
Treatment of canine atopic dermatitis: 2015 updated guidelines from the International Committee on Allergic Diseases of Animals (ICADA).犬特应性皮炎的治疗：动物过敏性疾病国际委员会（ICADA）2015年更新指南。
BMC Vet Res. 2015 Aug 16;11:210. doi: 10.1186/s12917-015-0514-6.
10
Long-term compassionate use of oclacitinib in dogs with atopic and allergic skin disease: safety, efficacy and quality of life.奥克拉替尼在患有特应性和过敏性皮肤病的犬类中的长期同情用药：安全性、有效性和生活质量
Vet Dermatol. 2015 Jun;26(3):171-9, e35. doi: 10.1111/vde.12194. Epub 2015 Feb 16.
Zotero 插件